ACM Research Inc

ACMR remains entrenched in a Stage 4 decline with sequential lower highs and lower lows under down-sloping EMAs. Medium-term bias stays bearish, reinforced by rejection at the 9/20 EMA zone. Short-term timing favors selling now on resistance rather than waiting for deep pullbacks. The long-term uptrend above the 200 DMA remains intact; a break below it would threaten the secular trend.

• ↑34% YoY revenue jump to $231.3M in Q1 2026 driven by ECP and packaging
• ↑Analysts expect EPS to increase from $1.02 to $1.54 over next year
• ↓P/E at 80.95 and negative earnings yield highlight valuation risk